Inhibition of breast tumor growth in mice after treatment with ceramide analog 315. | Profiles RNS

RCMI Coordinating Center (RCMI CC)

Inhibition of breast tumor growth in mice after treatment with ceramide analog 315.

Ponnapakkam T, Saulsberry T, Hill T, Hill-Odom M, Goyal N, Anbalagan M, Liu J, Foroozesh M. Inhibition of breast tumor growth in mice after treatment with ceramide analog 315. Anticancer Drugs. 2018 10; 29(9):898-903.

View in: PubMed

authors with profiles

Maryam Foroozesh

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support